Organism: human
Disease: squamous cell lung cancer
Disease: lung cancer
TumorSite: lung
AnatomicSiteTumor: lung
TumorStage: stage I–III
TumorGrade: well differentiated
TumorGrade: moderately differentiated
Sex: men
Sex: women
Age: mean age = 69.1
SampleTreatment: snap frozen tumor tissues
SampleTreatment: formalin fixed paraffin embedded sample
SampleTreatment: homogenized with a BioPulverizer in liquid nitrogen
SampleTreatment: reduction with 4.5 mM DTT at 60 degreesC for 20 min
SampleTreatment: alkylation with 11 mM iodoacetamide
SampleTreatment: digestion with trypsin overnight at 37 degreesC
SampleTreatment: lyophilized to dryness over 2 days
SampleTreatment: labeling with TMT reagent
ReductionReagent: DTT
AlkylationReagent: iodoacetamide
CleavageAgent: trypsin
Label: TMT reagent (229 Da on lysine and N-terminal)
Label: carboamidomethylation on cysteines (57 Da)
Label: oxidation of methionine (16 Da)
Label: pyroglutamine on N-terminal Glutamine residues (-17 Da)
Modification: oxidation of methionine
Modification: pyroglutamine
MaterialType: tumor tissues
MaterialType: peptides
AcquisitionMethod: liquid chromatography-tandem mass spectrometry (LC-MS/MS)
AcquisitionMethod: data independent acquisition (DIA)
AcquisitionMethod: data-dependent acquisition (DDA)
Separation: 4.6 mm ID x 100 mm column (XBridge, Waters)
Separation: C18 reversed-phase resin, 5 µm particle size, 100 Å pore size
Separation: C18, 75 µm ID x 50 cm, 2 µm, 100 Å
Separation: linear gradient of 5–35% solvent B over 240 min
FlowRateChromatogram: 0.6 ml/min
FlowRateChromatogram: 300 nl/min
Instrument: Q Exactive Plus
Instrument: quadrupole-orbital ion trap mass spectrometer
IonizationType: electrospray
FragmentationMethod: collision induced dissociation (CID)
CollisionEnergy: normalized collision energy 30
MS2MassAnalyzer: Orbitrap
NumberOfFractions: 12 concatenated fractions
SpikedCompound: 25 femtomoles of PRTC
AssayName: expression proteomics
AssayName: DIA
AssayName: TMT-based mass spectrometry
AssayName: RNAseq
AssayName: targeted exome sequencing
AssayName: CNV analysis
FactorValue: proteomic subtype (Inflamed, Redox, Mixed)
NumberOfSamples: 108 patients
NumberOfSamples: 116 tumors
TechnicalReplicate: pool replicates in each TMT 6-plex
PooledSample: tumor pool replicates
NumberOfTechnicalReplicates: 29 TMT 6-plex experiments